## MNST: Monster Beverage Corporation - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_20 -1.0% below STRENGTH zone (4.0-10.0%); PEG 1.88 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-6.2% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($71.04)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 6, Bearish: 0)

**1. Monster Beverage (MNST): Has the 40% Year‑to‑Date Rally Stretched Its Valuation?**
- Source: Simply Wall Street | 20251205T163446 | Neutral | Relevance: 100%
- Monster Beverage (MNST) has seen a significant rally of 40% year-to-date, prompting questions about its current valuation. The stock is mildly overvalued according to Simply Wall St's narrative fair value, trading at $73.26 against an estimated $72.23. Despite strong growth and strategic cost controls aimed at boosting margins, the analysis suggests future gains are contingent on these initiatives succeeding, with potential challenges from cost pressures and slowing category growth.

**2. Goldman Sachs raises Monster Beverage stock price target to $83 on growth**
- Source: Investing.com | 20251203T052100 | Bullish | Relevance: 100%
- Goldman Sachs raised its price target on Monster Beverage (NASDAQ:MNST) to $83.00 from $80.00, maintaining a Buy rating due to strong innovation and growth drivers. The investment bank expects high single-digit topline growth and low double-digit EPS growth for Monster Beverage next year. Other firms like RBC Capital, Morgan Stanley, BofA Securities, and Evercore ISI have also increased their price targets for Monster Beverage following a strong third-quarter performance.

**3. Monster Beverage energizes growth through innovation that reinforces, not replaces what consumers love**
- Source: FoodNavigator-USA.com | 20251205T143425 | Bullish | Relevance: 100%
- Monster Beverage Corporation is successfully growing volume despite widespread inflation by balancing innovative new products with its core fan favorites. The company believes innovation should complement its existing portfolio, expanding usage occasions and attracting new consumers without cannibalizing its established brands. Monster's 2026 innovation pipeline includes both zero-calorie options and limited-time offerings, as well as a new line called FLRT Energy specifically targeting female consumers.

**4. Tariffs aren’t impacting Monster Beverage … yet**
- Source: Food Business News | 20251205T090957 | Neutral | Relevance: 100%
- Monster Beverage Corp. announced that tariffs have not materially impacted its first-quarter 2025 results due to localized production and hedging strategies. While the company saw a slight dip in net sales and continued challenges in its alcohol brands segment, energy drink sales remained strong, and a convenience channel turnaround is anticipated. Co-CEO Rodney Sacks also announced his retirement from the CEO role.

**5. Is It Too Late To Consider Monster After Its 41% 2025 Surge?**
- Source: Simply Wall Street | 20251204T121129 | Somewhat-Bearish | Relevance: 100%
- Monster Beverage (MNST) has seen significant stock gains, up 41.4% year-to-date in 2025, but currently scores 0/6 on Simply Wall St's valuation checks, suggesting it is not undervalued. Both Discounted Cash Flow and Price-to-Earnings analyses indicate the stock is overvalued, with a DCF analysis pointing to a 19.3% overvaluation and its PE ratio significantly higher than industry and peer averages. Despite strong brand strength and global expansion, investors appear to be paying a premium for its growth story.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 12, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-03 | Piper Sandler | $85 | $75 | +13% |
| 2025-12-03 | Wells Fargo | $83 | $75 | +11% |
| 2025-12-03 | BMO Capital | $73 | $53 | +38% |
| 2025-12-01 | RBC Capital | $81 | $75 | +8% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-03 | Piper Sandler | main | Overweight |
| 2025-12-03 | Wells Fargo | main | Overweight |
| 2025-12-03 | BMO Capital | main | Market Perform |
| 2025-12-01 | RBC Capital | main | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 5 ($0.84M) |
| Sells | 4 ($6.05M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 31.1% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 6.9% (+3.2%)
- Blackrock Inc.: 6.1% (+3.7%)
- State Street Corpora: 3.9% (+8.0%)
- Alliancebernstein L.: 3.1% (-13.5%)
- LOOMIS SAYLES & CO L: 2.8% (+1.7%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-6.2% 5d) with bearish MACD, trend may be turning.
2. Insider selling cluster: $6.1M in recent transactions.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Analyst target momentum: 12 raises (avg +10%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 1.88 elevated, pricing in significant growth expectations. Forward P/E 33.2x stretched relative to 13% growth. Quality metrics strong (ROE 26%, ROA 17%, margin 22%). Balance sheet: strong liquidity (3.2x), low leverage (D/E 0.24). Analyst sentiment positive (12 raises, avg +10%). Insider selling cluster ($6.1M in 90 days), potential headwind. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $75.5B |
| Beta | 0.48 |
| 52W Range | $45.70 - $78.31 |
| Short Interest | 2.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.88 |
| Forward P/E | 33.2 |
| Current P/E | 37.5 |
| YoY Growth | 13.2% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 5.2% to -1.0% (-6.2% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.0pp (needs >4.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 59. OFD pattern: +SUL (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.99% (CS: 46) | Neutral |
| RSI_14 | 58.6 | Neutral |
| MACD Histogram | -0.08 | Bearish |
| vs SMA20 | 1.013x | Above |
| vs SMA50 | 1.054x | Above |
| vs SMA200 | 1.172x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $73.74
- **Stop Loss:** $71.04 (3.7% risk)
- **Target:** $76.44 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 185
- **Position Value:** $13,641.90
- **Portfolio %:** 13.64%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2026-02-26 (Est: $0.47)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.49 | $0.53 | +9.2% |
| 2025Q2 | $0.48 | $0.50 | +4.1% |
| 2025Q1 | $0.46 | $0.45 | -2.7% |
| 2024Q4 | $0.40 | $0.28 | -29.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*